← Every company
Bristol-Myers Squibb Co SEC Filings
What Bristol-Myers Squibb Co has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BMY overview →Filings on file
145
since Oct 27, 2016
Warning signs
0
none filed
Last results
Jul 30, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jul 25, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 18, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 18, 2024 | Executive or director change 8-K | Read ↗ |
| Mar 18, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 15, 2024 | Executive or director change 8-K | Read ↗ |
| Oct 31, 2023 | Executive or director change 8-K/A | Read ↗ |
| May 4, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 26, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 31, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 15, 2022 | Executive or director change 8-K | Read ↗ |
| Mar 17, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 9, 2021 | Executive or director change 8-K | Read ↗ |
| May 20, 2021 | Executive or director change 8-K | Read ↗ |
| May 4, 2021 | Executive or director change 8-K | Read ↗ |
| Mar 4, 2021 | Executive or director change 8-K | Read ↗ |
| Feb 10, 2021 | Executive or director change 8-K | Read ↗ |
| Jul 30, 2020 | Executive or director change 8-K | Read ↗ |
| Mar 12, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 24, 2020 | Executive or director change 8-K | Read ↗ |
| Dec 11, 2019 | Executive or director change 8-K/A | Read ↗ |
| Nov 20, 2019 | Executive or director changeAcquisition or sale completedMaterial agreementNew debt 8-K | Read ↗ |
| Sep 12, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 5, 2019 | Executive or director change 8-K | Read ↗ |
| Mar 8, 2019 | Executive or director change 8-K | Read ↗ |
| Sep 14, 2018 | Executive or director change 8-K | Read ↗ |
| Aug 28, 2018 | Executive or director change 8-K | Read ↗ |
| Jul 23, 2018 | Executive or director change 8-K | Read ↗ |
| Mar 1, 2018 | Executive or director change 8-K | Read ↗ |
| Jan 25, 2018 | Executive or director change 8-K | Read ↗ |
| Sep 13, 2017 | Executive or director change 8-K | Read ↗ |
| Jul 14, 2017 | Executive or director change 8-K | Read ↗ |
| May 5, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 23, 2017 | Executive or director change 8-K | Read ↗ |
| Mar 8, 2017 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2017 | Executive or director change 8-K | Read ↗ |
| Dec 21, 2016 | Executive or director change 8-K | Read ↗ |
Source: Bristol-Myers Squibb Co's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BMY
Company overviewEverything on BMY in one place, with the price.Insider tradingWhat BMY's own officers and directors buy and sell.Who owns itEvery manager reporting a position in BMY.Funds holding itWhich funds and ETFs hold BMY, and how big a bet.LobbyingWhat BMY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BMY's account, and who they worked for.Federal contractsWhat federal agencies pay BMY.PatentsWhat BMY is filing at the patent office.